85 related articles for article (PubMed ID: 10090753)
1. Characterization of (+) strand initiation and termination sequences located at the center of the equine infectious anemia virus genome.
Stetor SR; Rausch JW; Guo MJ; Burnham JP; Boone LR; Waring MJ; Le Grice SF
Biochemistry; 1999 Mar; 38(12):3656-67. PubMed ID: 10090753
[TBL] [Abstract][Full Text] [Related]
2. Compression of the DNA minor groove is responsible for termination of DNA synthesis by HIV-1 reverse transcriptase.
Lavigne M; Buc H
J Mol Biol; 1999 Jan; 285(3):977-95. PubMed ID: 9887262
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of uracil into viral DNA correlates with reduced replication of EIAV in macrophages.
Steagall WK; Robek MD; Perry ST; Fuller FJ; Payne SL
Virology; 1995 Jul; 210(2):302-13. PubMed ID: 7542416
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 reverse transcription. A termination step at the center of the genome.
Charneau P; Mirambeau G; Roux P; Paulous S; Buc H; Clavel F
J Mol Biol; 1994 Sep; 241(5):651-62. PubMed ID: 7520946
[TBL] [Abstract][Full Text] [Related]
5. DNA curvature controls termination of plus strand DNA synthesis at the centre of HIV-1 genome.
Lavigne M; Roux P; Buc H; Schaeffer F
J Mol Biol; 1997 Feb; 266(3):507-24. PubMed ID: 9067607
[TBL] [Abstract][Full Text] [Related]
6. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.
Lichtenstein DL; Craigo JK; Leroux C; Rushlow KE; Cook RF; Cook SJ; Issel CJ; Montelaro RC
Virology; 1999 Oct; 263(2):408-17. PubMed ID: 10544113
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus type 1 central DNA flap: dynamic terminal product of plus-strand displacement dna synthesis catalyzed by reverse transcriptase assisted by nucleocapsid protein.
Hameau L; Jeusset J; Lafosse S; Coulaud D; Delain E; Unge T; Restle T; Le Cam E; Mirambeau G
J Virol; 2001 Apr; 75(7):3301-13. PubMed ID: 11238856
[TBL] [Abstract][Full Text] [Related]
8. Amino acid mutations of the infectious clone from Chinese EIAV attenuated vaccine resulted in reversion of virulence.
Shen T; Liang H; Tong X; Fan X; He X; Ma Y; Xiang W; Shen R; Zhang X; Shao Y
Vaccine; 2006 Feb; 24(6):738-49. PubMed ID: 16202485
[TBL] [Abstract][Full Text] [Related]
9. Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain.
Zheng YH; Sentsui H; Sugita M; Nakaya T; Kishi M; Hagiwara K; Inoshima Y; Ishihara C; Kono Y; Lu JL; Ikuta K
Virology; 2000 Jan; 266(1):129-39. PubMed ID: 10612667
[TBL] [Abstract][Full Text] [Related]
10. Biochemical characterization of recombinant equine infectious anemia virus integrase.
Engelman A
Protein Expr Purif; 1996 Nov; 8(3):299-304. PubMed ID: 8936591
[TBL] [Abstract][Full Text] [Related]
11. Equine infectious anemia virus and human immunodeficiency virus DNA synthesis in vitro: characterization of the endogenous reverse transcriptase reaction.
Borroto-Esoda K; Boone LR
J Virol; 1991 Apr; 65(4):1952-9. PubMed ID: 1705993
[TBL] [Abstract][Full Text] [Related]
12. Long terminal repeats are not the sole determinants of virulence for equine infectious anemia virus.
Tu YB; Zhou T; Yuan XF; Qiu HJ; Xue F; Sun CQ; Wang L; Wu DL; Peng JM; Kong XG; Tong GZ
Arch Virol; 2007 Jan; 152(1):209-18. PubMed ID: 16932982
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of DNA replication by HIV-1 reverse transcriptase near the central termination sequence.
Ignatov ME; Berdis AJ; Le Grice SF; Barkley MD
Biochemistry; 2005 Apr; 44(14):5346-56. PubMed ID: 15807528
[TBL] [Abstract][Full Text] [Related]
14. The 5'-terminal region of the Aichi virus genome encodes cis-acting replication elements required for positive- and negative-strand RNA synthesis.
Nagashima S; Sasaki J; Taniguchi K
J Virol; 2005 Jun; 79(11):6918-31. PubMed ID: 15890931
[TBL] [Abstract][Full Text] [Related]
15. Cell specificity of the transcription-factor repertoire used by a lentivirus: motifs important for expression of equine infectious anemia virus in nonmonocytic cells.
Maury W; Bradley S; Wright B; Hines R
Virology; 2000 Feb; 267(2):267-78. PubMed ID: 10662622
[TBL] [Abstract][Full Text] [Related]
16. Long terminal repeat sequences from virulent and attenuated equine infectious anemia virus demonstrate distinct promoter activities.
Zhou T; Yuan XF; Hou SH; Tu YB; Peng JM; Wen JX; Qiu HJ; Wu DL; Chen HC; Wang XJ; Tong GZ
Virus Res; 2007 Sep; 128(1-2):58-64. PubMed ID: 17499380
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism of sequence-specific termination of lentiviral replication.
Berdis AJ; Stetor SR; LeGrice SF; Barkley MD
Biochemistry; 2001 Oct; 40(40):12140-9. PubMed ID: 11580289
[TBL] [Abstract][Full Text] [Related]
18. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus.
Raabe ML; Issel CJ; Montelaro RC
Virology; 1999 Jul; 259(2):416-27. PubMed ID: 10388665
[TBL] [Abstract][Full Text] [Related]
19. Combined amino acid mutations occurring in the envelope closely correlate with pathogenicity of EIAV.
Liang H; He X; Shen RX; Shen T; Tong X; Ma Y; Xiang WH; Zhang XY; Shao YM
Arch Virol; 2006 Jul; 151(7):1387-403. PubMed ID: 16502285
[TBL] [Abstract][Full Text] [Related]
20. Proviral DNA integration and transcriptional patterns of equine infectious anemia virus during persistent and cytopathic infections.
Rasty S; Dhruva BR; Schiltz RL; Shih DS; Issel CJ; Montelaro RC
J Virol; 1990 Jan; 64(1):86-95. PubMed ID: 2152836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
